James E. Dentzer - 20 Jan 2023 Form 4 Insider Report for CURIS INC (CRIS)

Role
President & CEO, Director
Signature
/s/ Diantha Duvall, Attorney-in-fact
Issuer symbol
CRIS
Transactions as of
20 Jan 2023
Net transactions value
$0
Form type
4
Filing time
24 Jan 2023, 15:05:04 UTC
Previous filing
03 Oct 2022
Next filing
21 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRIS Employee stock option (right to buy) Award $0 +1,000,000 $0.000000 1,000,000 20 Jan 2023 Common Stock 1,000,000 $0.7000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant described in this Form 4 filing vests as to 25% of the original shares on January 20, 2024 and as to an additional 6.25% of the original shares each successive quarter and until January 20, 2027.

Remarks:

Exhibit Index: 24.1 Power of Attorney